Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy

详细信息    查看全文

• 作者：Daryl Schantz ; Lee Benson ; Jonathan Windram ; Derek Wong…
• 关键词：Hypertrophic cardiomyopathy ; Mitral valve ; Myocardial delayed enhancement ; Cardiac magnetic resonance ; Children
• 刊名：Pediatric Cardiology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：37
• 期：4
• 页码：784-788
• 全文大小：403 KB
• 参考文献：1.Al-Mahdawi S, Chamberlain S, Chojnowska L, Michalak E, Nihoyannopoulos P, Ryan M, Kusnierczyk B, French JA, Gilligan DM, Cleland J et al (1994) The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 72:105–111CrossRef PubMed PubMedCentral
  2.Cardim N, Perrot A, Ferreira T, Pereira A, Osterziel KJ, Reis RP, Correia JF (2002) Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy. Am J Cardiol 90:128–132CrossRef PubMed
  3.Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation 105:539–542CrossRef PubMed
  4.De S, Borowski AG, Wang H, Nye L, Xin B, Thomas JD, Tang WH (2011) Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy. Am Heart J 162:262–267CrossRef PubMed PubMedCentral
  5.Forsey J, Benson L, Rozenblyum Friedberg MK, Mertens L (2014) Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging. J Am Soc Echocardiogr 27:215–221CrossRef PubMed
  6.Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC (2006) Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 48:2518–2523CrossRef PubMed
  7.Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Solomon SD (2002) Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical cardiomyopathy. Circulation 105:2992–2997CrossRef PubMed
  8.Maass A, Leinwand LA (2000) Animal models of hypertrophic cardiomyopathy. Curr Opin Cardiol 15:189–196CrossRef PubMed
  9.Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in the general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92:785–789CrossRef PubMed
  10.Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE (2001) Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutation. J Am Coll Cardiol 28:315–321CrossRef
  11.Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ (2011) Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 124:40–47CrossRef PubMed
  12.Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ (2001) Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 102:128–130CrossRef
  13.Rowin EJ, Maron MS, Lesser JR (2012) Maron BJ (2012) CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. J Am Coll Cardiol Imaging 5:119–122. doi:10.​1016/​j.​jcmg.​2011.​08.​020 CrossRef
  14.Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S (2006) Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1175–1181CrossRef PubMed
  15.Waldmuller S, Erdmann J, Binner P, Gelbrich G, Pakuweit S, Geier C, Timmermann B, Haremza J, Perrot A, Scheer S, Wachter R, Schulze-Waltrup N, Dermintzoglou A, Schonberger J, Zeh W, Jurmann B, Brodherr T, Borgel J, Farr M, Milting H, Blankenfeldt W, Reinhardt R, Ozcelik C, Osterziel KJ, Loeffler M, Maisch B, Regitz-Zagrosek V, Schunkert H, Scheffold T (2011) Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail 13:1185–1192CrossRef PubMed
  16.Wernicke D, Thiel C, Duja-Isac CM, Essin KV, Spindler M, Nunez DJ, Plehm R, Wessel N, Hammes A, Edwards RJ, Lippoldt A, Zacharias U, Stromer H, Neubauer S, Davies MJ, Morano I, Thierfelder L (2004) Alpha-tropomyosin mutations Asp175Asn and Glu180Gly affect cardiac function in transgenic rats in different ways. Am J Physiol Regul Integr Comp Physiol 287:R685–R695CrossRef PubMed
  
• 作者单位：Daryl Schantz (1) (3)
  Lee Benson (1)
  Jonathan Windram (2)
  Derek Wong (1)
  Andreea Dragulescu (1)
  Shi-Joon Yoo (1) (2)
  Luc Mertens (1)
  Mark Friedberg (1)
  Bahiyah Al Nafisi (2)
  Lars Grosse-Wortmann (1) (2)
  
  1. Department of Paediatrics, The Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
  3. The Variety Children’s Heart Centre, University of Manitoba, FE241-685 William Ave, Winnipeg, MB, R3E 0Z2, Canada
  2. Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  Cardiac Surgery
  Vascular Surgery
  
• 出版者：Springer New York
• ISSN：1432-1971

文摘

The hearts of patients with hypertrophic cardiomyopathy (HCM) show structural abnormalities other than isolated wall thickening. Recently, adult HCM patients have been found to have longer mitral valve leaflets than control subjects. The aim of the current study was to assess whether children and adolescents with HCM have similar measureable differences in mitral valve leaflet dimensions when compared to a healthy control group. Clinical and echocardiographic data from 46 children with myocardial hypertrophy and a phenotype and/or genotype consistent with sarcomeric HCM were reviewed. Cardiac magnetic resonance imaging studies were evaluated. The anterior and posterior mitral valve leaflet lengths and myocardial structure were compared to 20 healthy controls. The anterior mitral valve was longer in the HCM group than in the control group (28.4 ± 4.9 vs. 25.2 ± 3.6 mm in control patients, p = 0.013) as was the posterior mitral valve leaflet (16.3 ± 3.0 vs. 13.1 ± 2.3 mm for controls <0.0001). There was no correlation between the resting left ventricular outflow tract gradient and anterior mitral valve leaflet length, nor was the anterior mitral valve leaflet longer in those with systolic anterior motion of the mitral valve compared to those without (28.9 ± 6.1 vs. 28.1 ± 4.5 mm, p = 0.61). Children and adolescents with HCM have abnormally long mitral valve leaflets when compared with healthy control subjects. These abnormalities do not appear to result in, or be due to, obstruction to left ventricular outflow. The mechanism of this mitral valve elongation is not clear but appears to be independent of hemodynamic disturbances.